EU FUNDED PROJECT | FORCE REPAIR

Chronic wounds, clinically defined as wounds that usually do not heal in less than three months, affect up to 2% of the population in the industrial world, with incidents expected to rise significantly in the next years. However, current therapies remain insufficient and costly. To date, chronic wounds treatments have not been able to achieve reliable skin regeneration and reduce scar formation.

Chronic wounds, clinically defined as wounds that usually do not heal in less than three months, affect up to 2% of the population in the industrial world, with incidents expected to rise significantly in the next years. However, current therapies remain insufficient and costly. To date, chronic wounds treatments have not been able to achieve reliable skin regeneration and reduce scar formation.
May 4, 2023

Asphalion is the proud Regulatory partner of FORCE REPAIR, a project funded by the European Union dedicated to advancing chronic wound management by developing a smart, multifunctional, and cost-effective 3D-printed wound dressing. 

In addition to providing regulatory support to FORCE REPAIR partners, Asphalion will identify the appropriate regulatory framework at the start of the project and elaborate a regulatory roadmap, ensure regulatory compliance of processes and materials, and engage with regulators to ensure validation of the regulatory strategy. This will ensure the efficient translation of the results obtained in FORCE REPAIR to support the development of a product that can reach patients in the future.

We are happy to announce the launch of the #FORCEREPAIRproject website. Join us on our journey towards improving wound care management and reducing healthcare costs!

Check it out here!: FORCE REPAIR PROJECT WEBSITE

For further information, you can contact us at: info@asphalion.com

Search News & Events

  • Filter by category

Share

Related news and events

EVENT | 20th Biosimilar Medicines Conference by MFE

During these two interactive days, actors of the healthcare community alongside world experts in biosimilar medicines will gather and debate the evolving biosimilar medicines landscape and emerging trends. Discussion will focus on sharing good practices and setting collective aims to achieve the depth, breadth and speed of the use of biosimilar medicines as a lever to untap their transformative value.

New opening! | Pamplona office

At Asphalion, we are thrilled to announce the opening of our new office in Pamplona! This strategic decision reflects our commitment to being closer to

BUSINESS CASE | Transparency policy 0070

Have a look at this Business Case where Asphalion provided a leading global pharmaceutical company with full regulatory support for the management of Policy 0070

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule a meeting